ArticleCancer cell international2021

AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease.

Sigrid Nakken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.